Crocs, Inc.
NASDAQ:CROXApparel - Footwear & Accessories
+$1.47 today
- Market cap
- $7.44B
- Beta
- 1.56
- P/E (TTM)
- -61.1
- EPS (TTM)
- -$2.06
Volume 0.90M
Average 1.25M
CROX Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Crocs, Inc.NASDAQ: CROX
Accumulated OCI · Q3 FY2026 · quarter ended Sep 2026
Accumulated OCI remains negative
Q3 FY2026 Accumulated OCI was -$65.02M, compared with -$42.45M a year earlier.
Context
- Accumulated OCI amounted to 1.5% of total assets at the end of Q3 FY2026, up 0.5 pp from a year earlier.
- Accumulated OCI grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -53.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- (43.66M) USD
- Year-over-year change
- +67.1%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (43.66M) | +67.1% |
| FY2024 | 2024-12-31 | (132.65M) | -38.5% |
| FY2023 | 2023-12-31 | (95.77M) | +7.5% |
| FY2022 | 2022-12-31 | (103.49M) | -34.7% |
| FY2021 | 2021-12-31 | (76.84M) | — |
Accumulated OCI vs competitors
How CROX compares with its peers on the latest reported figures
- Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -53.2% is the 9th highest of 10, against a peer median of +22.4%.
- Accumulated OCI amounts to 1.5% of total assets for CROX, versus a peer median of 0.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | CHF 69.3M CHF | -94.3% | +60.1% | 1.9% | |
| Jun 2026 | €20.26M EUR | +163.4% | — | 0.4% | |
| Sep 2026 | $0 USD | +100.0% | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| May 2026 | -$6.1M USD | +19.3% | — | 0.3% | |
| Mar 2026 | -$13.74M USD | +22.4% | — | 4.6% | |
| May 2026 | -$17.82M USD | +34.4% | — | 0.9% | |
| Jun 2026 | -$35.52M USD | +10.7% | — | 1.9% | |
| May 2026 | -$37.39M USD | +3.4% | — | 2.7% | |
| Aug 2026 | -$39M USD | +87.3% | — | 0.1% | |
| Sep 2026 | -$65.02M USD | -53.2% | — | 1.5% | |
| Peer median (excluding CROX) | — | +22.4% | +60.1% | 0.6% | |
Competitors are the stored peer set for CROX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 213.26M | 191.63M | 149.29M | 180.49M | 130.35M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 217.18M | 329.19M | 331.23M | 283.91M | 333.06M |
| Inventory | 213.52M | 471.55M | 385.05M | 356.25M | 368.69M |
| Other Current Assets | 65K | 33.61M | 45.13M | 51.62M | 53.79M |
| Total Current Assets | 666.57M | 1.03B | 910.7M | 872.27M | 885.88M |
| Property, Plant & Equipment (Net) | 269.17M | 421.43M | 525.76M | 551.56M | 576.86M |
| Goodwill | 1.6M | 714.81M | 711.59M | 711.49M | 404.69M |
| Intangible Assets | 28.8M | 1.8B | 1.79B | 1.78B | 1.32B |
| Long-term Investments | 3.66M | 3.25M | 3.81M | 3.19M | 3.56M |
| Tax Assets | 567.2M | 528.28M | 667.97M | 872.35M | 935.05M |
| Other Non-current Assets | 8.07M | 7.87M | 31.45M | 24.21M | 44.03M |
| Total Non-current Assets | 878.5M | 3.48B | 3.73B | 3.94B | 3.29B |
| Total Assets | 1.55B | 4.5B | 4.64B | 4.81B | 4.17B |
| Account Payables | 162.15M | 230.82M | 260.98M | 264.9M | 266.09M |
| Short-term Debt | 42.93M | 81.82M | 85.6M | 68.55M | 0 |
| Tax Payables | 16.28M | 89.21M | 65.95M | 108.69M | 47.31M |
| Deferred Revenue | 100K | 6.8M | 0 | 0 | 0 |
| Other Current Liabilities | 103.84M | 177.15M | 215.53M | 216.8M | 184.84M |
| Total Current Liabilities | 388.24M | 641.27M | 698.3M | 740.21M | 700.13M |
| Long-term Debt | 771.39M | 2.3B | 1.64B | 1.35B | 1.23B |
| Deferred Tax Liabilities | 176K | 302.03M | 12.91M | 4.09M | 882K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 222.12M | 227.42M | 567.94M | 599.38M | 653.26M |
| Total Non-current Liabilities | 1.14B | 3.04B | 2.49B | 2.24B | 2.18B |
| Total Liabilities | 1.53B | 3.68B | 3.19B | 2.98B | 2.88B |
| Common Stock | 106K | 110K | 110K | 110K | 111K |
| Retained Earnings | 1.28B | 1.82B | 2.61B | 3.56B | 3.48B |
| Accumulated OCI | (76.84M) | (103.49M) | (95.77M) | (132.65M) | (43.66M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 14.08M | 817.93M | 1.45B | 1.84B | 1.29B |
| Total Debt | 963.56M | 2.59B | 2B | 1.7B | 1.61B |
| Net Debt | 750.3M | 2.4B | 1.85B | 1.52B | 1.48B |
Crocs, Inc.
NASDAQ:CROX
Intrinsic Alpha fair value
Locked
Current Price
$162.76
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.